Grifols: Brookfields potential $6.8 bln offer undervalues the firm
Recasts with Grifols' comments in paragraph 1, detail and context
MADRID, Nov 19 (Reuters) -Grifols GRLS.MC said on Tuesday that Canadian investment fund Brookfield's potential 6.45 billion euro ($6.8 billion) offer significantly undervalued the Spanish drugmaker's prospects and long-term potential.
Earlier on Tuesday, Brookfield BAM.TO said it was considering a public offer for Grifols at 10.50 euros per A share and 7.62 euros per B share, implying a company valuation of 6.45 billion euros.
The proposal is non-binding, Brookfield said in a filing to the Spanish stock market regulator.
The Canadian private equity firm said inJuly it was interested in making a takeover bid jointly with the Grifols family with the ultimate goal of taking the company private.
Grifols said its board would meet later on Tuesday to consider the potential offer, but that, given the valuation, it would not be in a position to recommend that shareholders accept it.
Grifols shares were down 6% at 1310 GMT, one of the biggest falls on Spain's blue-chip IBEX 35 index.
The company has lost about 30% of its market value since January, when short-seller fund Gotham City Research accused Grifols of overstating earnings and understating debt, which Grifols denied.
On Tuesday, an investigating magistrate at Spain's High Court opened a probe into Gotham's actions saying it had found enough evidence to merit an investigation into the possible violation of market and consumer protection laws.
($1 = 0.9472 euros)
Reporting by Inti Landauro and Javi West Larrañaga. Editing by Jason Neely and Mark Potter
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
